Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | Director | May 01, 2017 | May 04, 2017 |
| WELLTOWER INC.WELL · Entity 2853 | Director | February 07, 2019 | February 11, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date May 01, 2017 · Filed May 04, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,232 |
Reported balance
After 2017-05-01 transaction · row 1
1 source rowRow 1 · 2017-05-01 · Grant · Acquired 1,230 · Balance 11,232 F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's Common Stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's Common Stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule.
WELLTOWER INC.
Report date February 07, 2019 · Filed February 11, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,588 |
Reported balance
After 2019-02-07 transaction · row 1
1 source rowRow 1 · 2019-02-07 · Grant · Acquired 689 · Balance 13,588 F1: These shares represent deferred stock units that were granted without cash consideration on February 7, 2019 under the Welltower Inc. 2016 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares represent deferred stock units that were granted without cash consideration on February 7, 2019 under the Welltower Inc. 2016 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on the first anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 24, 2012 Filed Aug 27, 2012 22:53 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $74.89 | $0.00 |
DisclosureSEC source: 0001127602-12-025191 · form4.xml · derivative · entry 3 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2013-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2012 Filed Aug 27, 2012 22:53 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $84.37 | $421,832.50 |
DisclosureSEC source: 0001127602-12-025191 · form4.xml · nonDerivative · entry 2 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,304 F1 · price: The price reported is an average price. The prices ranged from $84.3501 to $84.3801 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| August 24, 2012 Filed Aug 27, 2012 22:53 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 5,000 | $74.89 | $374,450.00 |
DisclosureSEC source: 0001127602-12-025191 · form4.xml · nonDerivative · entry 1 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,304 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2012 Filed May 21, 2012 22:10 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $50.78 | $0.00 |
DisclosureSEC source: 0001127602-12-017674 · form4.xml · derivative · entry 3 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires 2013-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2012 Filed May 21, 2012 22:10 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 16,000 | $69.06 | $1,104,988.80 |
DisclosureSEC source: 0001127602-12-017674 · form4.xml · nonDerivative · entry 2 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,304 F1 · price: The price reported is an average price. The prices ranged from $69.05 to $69.09 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| May 18, 2012 Filed May 21, 2012 22:10 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 16,000 | $50.78 | $812,480.00 |
DisclosureSEC source: 0001127602-12-017674 · form4.xml · nonDerivative · entry 1 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,304 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 27, 2012 Filed May 1, 2012 23:58 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 5,000 | $71.64 Strike: $71.64 | $358,200.00 |
DisclosureSEC source: 0001127602-12-015231 · form4.xml · derivative · entry 2 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2022-04-27 Read SEC document |
| April 27, 2012 Filed May 1, 2012 23:58 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-015231 · form4.xml · nonDerivative · entry 1 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,304 F1 · shares: The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan (the "Director Program") and vested immediately because the director has three years or more of prior continuous service as a director. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case, payment will occur according to the elected deferral schedule. Read SEC document |
| February 13, 2012 Filed Feb 15, 2012 01:29 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $58.61 | $0.00 |
DisclosureSEC source: 0001127602-12-006022 · form4.xml · derivative · entry 3 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2012-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2012 Filed Feb 15, 2012 01:29 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 5,000 | $68.30 | $341,500.00 |
DisclosureSEC source: 0001127602-12-006022 · form4.xml · nonDerivative · entry 2 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,909 Read SEC document |
| February 13, 2012 Filed Feb 15, 2012 01:29 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 5,000 | $58.61 | $293,050.00 |
DisclosureSEC source: 0001127602-12-006022 · form4.xml · nonDerivative · entry 1 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,909 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2011 Filed Dec 22, 2011 21:45 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $56.30 | $0.00 |
DisclosureSEC source: 0001127602-11-033104 · form4.xml · derivative · entry 3 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires 2012-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2011 Filed Dec 22, 2011 21:45 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 14,267 | $63.14 | $900,818.38 |
DisclosureSEC source: 0001127602-11-033104 · form4.xml · nonDerivative · entry 2 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,909 Read SEC document |
| December 22, 2011 Filed Dec 22, 2011 21:45 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 16,000 | $56.30 | $900,800.00 |
DisclosureSEC source: 0001127602-11-033104 · form4.xml · nonDerivative · entry 1 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2011 Filed Apr 28, 2011 00:20 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 5,000 | $54.69 Strike: $54.69 | $273,450.00 |
DisclosureSEC source: 0001127602-11-013862 · form4.xml · derivative · entry 2 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2021-04-25 Read SEC document |
| April 25, 2011 Filed Apr 28, 2011 00:20 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-013862 · form4.xml · nonDerivative · entry 1 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,176 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Equity Incentive Program under the Amgen Inc. 2009 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director has had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| April 26, 2010 Filed Apr 28, 2010 23:09 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 5,000 | $58.43 Strike: $58.43 | $292,150.00 |
DisclosureSEC source: 0001127602-10-012372 · form4.xml · derivative · entry 2 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2020-04-26 Read SEC document |
| April 26, 2010 Filed Apr 28, 2010 23:09 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,711 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-012372 · form4.xml · nonDerivative · entry 1 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,348 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's 2009 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director has had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| April 28, 2009 Filed Apr 30, 2009 17:32 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $50.44 | $0.00 |
DisclosureSEC source: 0001127602-09-010056 · form4.xml · derivative · entry 3 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2016-04-28 Read SEC document |
| April 28, 2009 Filed Apr 30, 2009 17:32 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,982 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-09-010056 · form4.xml · nonDerivative · entry 1 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,982 F1 · security: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous services as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| October 29, 2008 Filed Oct 29, 2008 22:06 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $28.97 | $0.00 |
DisclosureSEC source: 0001181431-08-058744 · rrd221855.xml · derivative · entry 3 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires 2009-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2008 Filed Oct 29, 2008 22:06 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 16,000 | $60.00 | $960,000.00 |
DisclosureSEC source: 0001181431-08-058744 · rrd221855.xml · nonDerivative · entry 2 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,655 Read SEC document |
| October 29, 2008 Filed Oct 29, 2008 22:06 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 16,000 | $28.97 | $463,500.80 |
DisclosureSEC source: 0001181431-08-058744 · rrd221855.xml · nonDerivative · entry 1 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,655 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2008 Filed May 1, 2008 21:12 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 5,000 | $42.13 Strike: $42.13 | $210,650.00 |
DisclosureSEC source: 0001181431-08-028021 · rrd204685.xml · derivative · entry 2 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2015-04-29 Read SEC document |
| April 29, 2008 Filed May 1, 2008 21:12 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 2,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-08-028021 · rrd204685.xml · nonDerivative · entry 1 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,655 F1 · security: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director hah had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| April 26, 2007 Filed Apr 30, 2007 17:32 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 5,000 | $62.55 Strike: $62.55 | $312,750.00 |
DisclosureSEC source: 0001181431-07-027933 · rrd155998.xml · derivative · entry 2 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2014-04-26 Read SEC document |
| April 26, 2007 Filed Apr 30, 2007 17:32 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,598 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-07-027933 · rrd155998.xml · nonDerivative · entry 1 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,282 F1 · security: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| March 15, 2006 Filed Mar 17, 2006 22:05 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $74.89 | $0.00 |
DisclosureSEC source: 0001181431-06-018760 · rrd111628.xml · derivative · entry 2 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2013-03-15 Read SEC document |
| March 15, 2006 Filed Mar 17, 2006 22:05 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-06-018760 · rrd111628.xml · nonDerivative · entry 1 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,684 F1 · balance_after: Includes shares equivalent to Restricted Stock Units, which were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan, which were paid in shares of the Company's common stock on a one-to-one basis shortly after vesting and which were previously identified as Restricted Stock Units on Table I. Read SEC document |
| August 04, 2005 Filed Aug 5, 2005 17:31 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 16,000 | $12.28 Strike: $12.28 | $196,500.80 |
DisclosureSEC source: 0001181431-05-044918 · rrd88516.xml · derivative · entry 3 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires 2008-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2005 Filed Aug 5, 2005 17:31 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 16,000 | $82.77 | $1,324,320.00 |
DisclosureSEC source: 0001181431-05-044918 · rrd88516.xml · nonDerivative · entry 2 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,349 Read SEC document |
| August 04, 2005 Filed Aug 5, 2005 17:31 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 16,000 | $12.28 | $196,500.80 |
DisclosureSEC source: 0001181431-05-044918 · rrd88516.xml · nonDerivative · entry 1 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2005 Filed Mar 17, 2005 01:19 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO(Right to Buy) · Derivative | 5,000 | $0.00 Strike: $58.61 | $0.00 |
DisclosureSEC source: 0001181431-05-017376 · rrd72869.xml · derivative · entry 3 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2015-03-15 Read SEC document |
| March 15, 2005 Filed Mar 17, 2005 01:19 UTC | AMGEN INC AMGN · Entity 2832 | GrantRestricted Stock Units | 1,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-05-017376 · rrd72869.xml · nonDerivative · entry 2 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,706 F1 · security: (DIR 03.15.05) The Restriced Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:04 UTC | AMGEN INC AMGN · Entity 2832 | GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $859.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015952 · rrd36765.xml · derivative · entry 3 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:04 UTC | AMGEN INC AMGN · Entity 2832 | GrantRestricted Stock Units | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-015952 · rrd36765.xml · nonDerivative · entry 2 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643 F1 · security: (DIR 03.15.04) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| July 28, 2003 Filed Jul 29, 2003 20:35 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 3,200 | $0.00 Strike: $13.73 | $0.00 |
DisclosureSEC source: 0001181431-03-015943 · rrd14435.xml · derivative · entry 5 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,200 shares Expires 2007-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: 0 F1 · balance_after: 0 Read SEC document |
| July 28, 2003 Filed Jul 29, 2003 20:35 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNQSO (Right to Buy) · Derivative | 44,000 | $0.00 Strike: $13.17 | $0.00 |
DisclosureSEC source: 0001181431-03-015943 · rrd14435.xml · derivative · entry 4 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 44,000 shares Expires 2007-12-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: 0 F1 · balance_after: 0 Read SEC document |
| July 28, 2003 Filed Jul 29, 2003 20:35 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 47,200 | $69.00 | $3,256,800.00 |
DisclosureSEC source: 0001181431-03-015943 · rrd14435.xml · nonDerivative · entry 3 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Read SEC document |
| July 28, 2003 Filed Jul 29, 2003 20:35 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 44,000 | $13.17 | $579,563.60 |
DisclosureSEC source: 0001181431-03-015943 · rrd14435.xml · nonDerivative · entry 2 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2003 Filed Jul 29, 2003 20:35 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 3,200 | $13.73 | $43,950.08 |
DisclosureSEC source: 0001181431-03-015943 · rrd14435.xml · nonDerivative · entry 1 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.